NCT Number: NCT01138319
Biomarkers in Patients With Acute Myeloid Leukemia
RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.
PURPOSE: This research study is studying biomarkers in patients with acute myeloid leukemia.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Observational
About this study
OBJECTIVES:
- To determine whether clonally expanded somatic mitochondrial DNA mutations are associated with acute myeloid leukemia.
OUTLINE: Genomic DNA from blood samples obtained at diagnosis, remission, and relapse are analyzed for mitochondrial DNA mutations via PCR.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
DISEASE CHARACTERISTICS:
- Diagnosis of acute myeloid leukemia
- Available blood samples from diagnosis, remission, and relapse
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
Treatment and study plan
mutation analysis
Geneticpolymerase chain reaction
Geneticlaboratory biomarker analysis
OtherPrimary outcomes
-
Association between clonally expanded somatic mitochondrial DNA mutations and acute myeloid leukemia
Sponsors and collaborators
Lead sponsor
Children's Oncology Group
Network
Collaborators
- National Cancer Institute (NCI)
Registry information
Official study title
Mitochondrial Mutations and AML
Important dates
- Study start
- 2009
- Primary completion
- 2010
- First posted
- Jun 7, 2010
- Registry last updated
- May 6, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
NCT00081874
Bone Marrow Diseases, Chronic Disease
Houston, Texas, United States
View Trial DetailsA Phase 1/2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Hematologic and Myeloproliferative Malignancies
NCT02158858
Blood Coagulation Disorders, Blood Platelet Disorders
Phoenix, Arizona, United States
View Trial DetailsBusulfan, Etoposide, and Total-Body Irradiation in Treating Patients Undergoing Donor Stem Cell or Bone Marrow Transplant for Advanced Hematologic Cancer
NCT00534430
Anemia, Anemia, Refractory
View Trial DetailsTocilizumab for the Prevention of Graft Versus Host Disease After Cord Blood Transplantation
NCT03434730
Acute Leukemia, Acute Lymphoblastic Leukemia
New York, United States
View Trial Details